THE US Food and Drug
Administration has approved
Diclegis (doxylamine succinate and
pyridone hydrochloride) to treat
pregnant women experiencing
nausea and vomiting.
Diclegis, marketed by Canadian
firm Duchesnay, is a delayed
release daily tablet intended for
women who have not responded to
dietary and lifestyle modifications.The above article was sent to subscribers in Pharmacy Daily's issue from 10 Apr 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 Apr 13
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.